These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7037586)

  • 1. Hormonal and metabolic changes in hepatic cirrhosis.
    Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H
    Horm Metab Res; 1982 Jan; 14(1):34-9. PubMed ID: 7037586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucoregulatory hormones in hepatic cirrhosis.
    Saini JS; Pruthi HS; Naqvi S; Karnani I; Shetty KJ
    J Assoc Physicians India; 1992 Jul; 40(7):448-51. PubMed ID: 1484025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic alpha- and beta-cell function and metabolic changes during oral L-alanine and glucose administration: comparative studies between normal, diabetic and cirrhotic subjects.
    Hattori T; Hotta N; Ohara K; Shinoda H; Kunieda T; Nomura T; Kakuta H; Tamagawa T; Sakamoto N
    Nagoya J Med Sci; 1989 Mar; 51(1-4):7-16. PubMed ID: 2671746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in circulating fuels, pancreatic hormones and liver glycogen concentration in fasting or suckling newborn pigs.
    Pégorier JP; Duée PH; Assan R; Peret J; Girard J
    J Dev Physiol; 1981 Jun; 3(3):203-17. PubMed ID: 7040535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose turnover in compensated hepatic cirrhosis.
    Piniewska DM; McCulloch AJ; Bramble MG; Taylor R; Record CO; Alberti KG
    Horm Metab Res; 1986 Dec; 18(12):834-7. PubMed ID: 3817749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
    Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
    Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and metabolic response to physical exercise in hyperinsulinemic and non-hyperinsulinemic type 2 diabetics.
    Hübinger A; Franzen A; Gries FA
    Diabetes Res; 1987 Feb; 4(2):57-61. PubMed ID: 3555953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
    Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP
    J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
    Krentz AJ; Williams AC; Nattrass M
    Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amino acid response to protein ingestion in patients with liver cirrhosis.
    Marchesini G; Bianchi G; Zoli M; Dondi C; Forlani G; Melli A; Bua V; Vannini P; Pisi E
    Gastroenterology; 1983 Aug; 85(2):283-90. PubMed ID: 6345256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose resistance contributes to diabetes mellitus in cirrhosis.
    Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
    Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.